Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Zura Bio (NASDAQ:ZURA)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Zura Bio Charts.

Zura Bio (NASDAQ:ZURA)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Zura Bio Charts.

Zura Bio Ltd News

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (2 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 days ago) • Edgar (US Regulatory)

Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
Thursday 14 November 2024 (2 days ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (1 week ago) • Edgar (US Regulatory)

Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
Thursday 7 November 2024 (1 week ago) • Business Wire

Form 8-K - Current report
Wednesday 30 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Zura Bio to Participate in Two Upcoming Investor Conferences in November
Wednesday 30 October 2024 (2 weeks ago) • Business Wire

Form 8-K - Current report
Tuesday 29 October 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 18 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Wednesday 11 September 2024 (2 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 10 September 2024 (2 months ago) • Edgar (US Regulatory)

More Zura Bio Ltd News Articles

Super Micro Computer

Decentral Life (PK)

Elite Pharmaceuticals (QB)

Kraig Biocraft Laborator... (QB)

Halozyme Therapeutics

CyberFuels (PK)

Moon Equity (PK)

Accredited Solutions (PK)

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions